Company Sinocelltech Group Limited

Equities

688520

CNE100003ZL3

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Ratings for Sinocelltech Group Limited

EPS Revisions

Annual profits - Rate of surprise

Sector Bio Therapeutic Drugs

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 30/04/2024 am IST			5-day change	1st Jan Change
49.84 ^CNY	+1.10%		+0.18%	-7.48%

25/04	Sinocelltech Group Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
18/04	Sinocelltech Forecasts Return to Profit in Q1	MT

Sinocelltech Group Ltd is a China-based company mainly engaged in the research, development and industrialization of biopharmaceutical products. The Company focuses on monoclonal antibodies, recombinant proteins and vaccine products. Its main products are SCT800, SCT200, SCT-I10A, SCT400, SCT510, SCT1000 and SCT630, among others. The Company is also engaged in asset leasing business and payment collection business.

Number of employees: 2,313

CNY in Million	2022	Weight	2023	Weight	Delta
Recombinant Protein Drug 94.3 %	1,004	98.1 %	1,780	94.3 %	+77.38%
Antibody Drug 5.5 %	20	1.9 %	103	5.5 %	+426.02%
Vaccine 0.2 %	-	-	4	0.2 %	-

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	1,023	100.0 %	1,887	100.0 %	+84.46%

Managers	Title	Age	Since
Liang Zhi Xie CEO	Chief Executive Officer	58	23/07/23
Jie Ma DFI	Director of Finance/CFO	52	25/23/25
Gui Fen Zhao BRD	Director/Board Member	57	12/17/12
Li Ming Tang BRD	Director/Board Member	44	01/16/01
Yang Wang BRD	Director/Board Member	65	01/10/01
Yan Zeng IRC	Investor Relations Contact	-	-
Zhang Hua Lan PRN	Corporate Officer/Principal	61	01/19/01

Members of the board	Title	Age	Since
Xiao Chuan Wang BRD	Director/Board Member	69	17/19/17
Zhi Guo Su BRD	Director/Board Member	70	17/19/17
Wei Qiang Han BRD	Director/Board Member	70	17/22/17
Song Zhang BRD	Director/Board Member	43	16/19/16
Liang Zhi Xie CEO	Chief Executive Officer	58	23/07/23
Yang Wang BRD	Director/Board Member	65	01/10/01
Zhang Hua Lan PRN	Corporate Officer/Principal	61	01/19/01
Yan Min Tang BRD	Director/Board Member	51	12/17/12
Xun Li CHM	Chairman	45	17/19/17
Ji Lei Jia BRD	Director/Board Member	35	17/19/17

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	445,335,714	89,416,678 ( 20.08 %)	0	20.08 %

Name	Equities	%	Valuation
Liang Zhi Xie 64.65 %	286,573,833	64.65 %	1 625 M ¥
Tianjin Shenzhou Anyuan Mgmt Consulting Partnership LP 4.941 %	21,900,000	4.941 %	124 M ¥
H An Yuan Li 4.513 %	20,006,015	4.513 %	113 M ¥
Tianjin Shenzhou Anheng Mgmt Consulting Partnership LP 1.647 %	7,300,000	1.647 %	41 M ¥
Zhejiang Qingsong Investment Management Co., Ltd. 1.599 %	7,089,953	1.599 %	40 M ¥
Wen Jun Zhang 1.007 %	4,465,566	1.007 %	25 M ¥
Tianjin Yingya Equity Investment Fund Management Co. Ltd. 0.8396 %	3,721,488	0.8396 %	21 M ¥
Yong Zhou 0.6223 %	2,758,565	0.6223 %	16 M ¥
Huadong Qiangzhen Tianjin Enterprise Mgt Enterprise LP 0.4587 %	2,033,050	0.4587 %	12 M ¥
China Merchants Fund Management Co., Ltd. 0.4569 %	2,025,232	0.4569 %	11 M ¥

Name	Equities	%	Valuation
Caitong Fund Management Co., Ltd. 0.5951 %	2,058,762	0.5951 %	12 M ¥
Nuode Asset Management Co., Ltd. 0.5311 %	1,837,368	0.5311 %	10 M ¥
UBS Asset Management Switzerland AG 0.2093 %	724,187	0.2093 %	4 M ¥
China Life Pension Co., Ltd. 0.1794 %	620,732	0.1794 %	4 M ¥
Everbright Securities Asset Management Co., Ltd. 0.1585 %	548,313	0.1585 %	3 M ¥

Sinocelltech Group Ltd.

No. 31, Kechuang 7th Street Beijing Eco & Tech Development Zone

100176, Beijing

http://www.sinocelltech.com

address Sinocelltech Group Limited(688520)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

49.84 CNY

Average target price

69 CNY

Spread / Average Target

+38.44%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
SINOCELLTECH GROUP LIMITED	-7.48%	3.07B
REGENERON PHARMACEUTICALS, INC.	+8.96%	105B
VERTEX PHARMACEUTICALS INCORPORATED	-1.43%	104B
ARGENX SE	+4.40%	22.94B
BIONTECH SE	-12.15%	22.34B
GENMAB A/S	-4.36%	19.25B
WUXI APPTEC CO., LTD.	-39.98%	17.08B
BEIGENE, LTD.	-10.04%	16.96B
SAREPTA THERAPEUTICS, INC.	+38.61%	12.63B
VIKING THERAPEUTICS, INC.	+313.59%	8.49B

Bio Therapeutic Drugs